Clinical Trial

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

Study acronym: GIO B
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to examine the effect of prolonged (72 hour) administration of glucagon compared to placebo on energy expenditure in healthy, non-diabetic, obese subjects.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2017-05-02; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2018-07-10
Status change: Not Yet Recruiting → Recruiting 2017-11-27
Trial Details
NCT Number NCT03139305
Lead Sponsor AdventHealth Translational Research Institute
Conditions Obesity
Enrollment 30 participants
Start Date 2017-10-24
Primary Completion 2018-02-14 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-30